Harvard Bioscience
HBIO
HBIO
79 hedge funds and large institutions have $74M invested in Harvard Bioscience in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
58% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 19
Holders
79
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.07M | |
| 2 | +$949K | |
| 3 | +$894K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$673K |
| 5 |
2C
272 Capital
Dallas,
Texas
|
+$437K |
Top Sellers
| 1 | -$2.84M | |
| 2 | -$1.08M | |
| 3 | -$475K | |
| 4 |
Renaissance Technologies
New York
|
-$384K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$347K |